Nuclear Speckle-Related Protein 70 Binds to Serine/Arginine-Rich Splicing Factor-1 and -2 Via an Arginine/Serine-Like Region and Counteracts Their Alternative Splicing Activity by Kim, CH et al.
Nuclear Speckle-related Protein 70 Binds to Serine/Arginine-
rich Splicing Factors 1 and 2 via an Arginine/Serine-like
Region and Counteracts Their Alternative Splicing Activity*□S
Received for publication, September 1, 2015, and in revised form, January 11, 2016 Published, JBC Papers in Press, January 21, 2016, DOI 10.1074/jbc.M115.689414
Chang-Hyun Kim‡, Young-Dae Kim§, Eun-Kyung Choi‡, Hye-Ran Kim‡, Bo-Ra Na‡, Sin-Hyeog Im¶,
and Chang-Duk Jun‡1
From the ‡School of Life Sciences, Immune Synapse Research Center, Gwangju Institute of Science and Technology, Gwangju 500-
712, Korea, the §Stem Cell Research Center, Korea Research Institute of Bioscience and Biotechnology, 125 Gwahak-ro, Yuseng-gu,
Daejeon 3414, Korea, and the ¶Academy of Immunology andMicrobiology, Institute for Basic Science, and Division of Integrative
Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang 790-784, Korea
Nuclear speckles are subnuclear storage sites containing
pre-mRNA splicing machinery. Proteins assembled in nuclear
speckles are known to modulate transcription and pre-mRNA
processing. We have previously identified nuclear speckle-re-
latedprotein 70 (NSrp70) as anovel serine/arginine (SR)-related
protein that co-localizes with classical SR proteins such as ser-
ine/arginine-rich splicing factor 1 (SRSF1 or ASF/SF2) and
SRSF2 (SC35). NSrp70mediates alternative splice site selection,
targeting several pre-mRNAs, including CD44 exon v5. Here we
demonstrated thatNSrp70 interacts physically with two SRpro-
teins, SRSF1 and SRSF2, and reverses their splicing activity in
terms of CD44 exon v5 as exon exclusion. The NSrp70 RS-like
regionwas subdivided into three areas. Deletion of the first argi-
nine/serine-rich-like region (RS1) completely abrogated bind-
ing to the SR proteins and to target mRNA and also failed to
induce splicing of CD44 exon v5, suggesting that RS1 is critical
for NSrp70 functioning. Interestingly, RS1 deletion also
resulted in the loss of NSrp70 and SR protein speckle position-
ing, implying a potential scaffolding role for NSrp70 in nuclear
speckles. NSrp70 contains an N-terminal coiled-coil domain
that is critical not only for self-oligomerizationbut also for splic-
ing activity. Consistently, deletion of the coiled-coil domain
resulted in indefinite formation of nuclear speckles. Collec-
tively, these results demonstrate that NSrp70 acts as a new
molecular counterpart for alternative splicing of target RNA,
counteracting SRSF1 and SRSF2 splicing activity.
The mammalian cell nucleus contains non-membranous
subnuclear bodies such as the nucleolus, Cajal bodies, promy-
elocytic leukemia bodies, and nuclear speckles. These bodies
are generally classified by the presence of a distinct group of
proteins and RNAs within them (1, 2). Nuclear speckles are
irregular, punctuate structures that vary in size and shape at the
immunofluorescencemicroscope level and are located in inter-
chromatin regions of the nucleoplasm of mammalian cells (3,
4). Several reports have demonstrated that nuclear speckles
serve as storage/assembly sites for pre-mRNA splicingmachin-
ery and, therefore, elaborately regulate gene expression (2).
Nuclear speckles are known to be functional centers that spa-
tially organize transcriptional and posttranscriptional mecha-
nisms of gene regulation. RNA-binding proteins involved in
transcription and pre-mRNA processing, such as small nuclear
ribonucleoprotein and arginine/serine-rich family factors (SR
protein, SR-related protein), are associated with nuclear speck-
les (5, 6). Remarkably, two classical SR proteins, SRSF1 and
SRSF2, are well known components of nuclear speckles. These
SR proteinsmodulate both constitutive and alternative splicing
by assembly of the mature spliceosome (7, 8).
In a previous report, we identified a novel SR-related protein,
nuclear speckle-related protein 70 (NSrp70), that modulates
alternative splicing site selection of several mRNAs in vivo,
including Tra21 v2, Fas v6, and CD44 exon v5. Interestingly,
NSrp70 co-localizes and interacts physically with SRSF1 and
SRSF2 in nuclear speckles through its RS-like region (9). How-
ever, its physiological functions are largely unknown. There-
fore, in this study, our primary goal was to investigate whether
NSrp70 synergizes the alternative splicing actions with SRSF1
and SRSF2, or whether it counteracts these functions. In addi-
tion, because the binding site in the RS-like region of NSrp70
has not yet been clearly determined, we generated deletion
mutants and determinedwhich site is critical for the function in
terms of speckle localization with SRSF1 and SRSF2 and the
alternative splicing of target mRNAs.
Several sources of evidence have suggested that RNA-bind-
ing proteins are related to functional aggregation to form para-
speckles in the nucleus and stress granules in the cytoplasm as
RNA-protein granules (10). For example, proteins of the Dro-
sophila behavior/human splicing (DBHS)2 family, including
PSF, p54nrb, and PSPC1 (Paraspeckle component 1) are major
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components of paraspeckles (11). Interestingly, it has been
demonstrated that the coiled-coil (CC) domain in DBHS pro-
teins is important for self-dimerization formation and paras-
peckle targeting. When DBHS proteins bind to their target
DNA, the CC domain helps to form a condensational assembly,
therefore enriching recruitment of other functional factors that
then rapidly promote a specific response (12, 13). In silico anal-
ysis revealed that NSrp70 also contains a predicted CC domain.
We therefore questioned whether this domain is involved in
dimerization or multimerization of NSrp70 and whether it
plays a role in condensational assembly by recruiting other fac-
tors, including SRSF1 and SRSF2, in nuclear speckles.
SRSF1 and SRSF2 contain two unique structures: one or two
N-terminal RNA recognition motifs (RRMs) that determine
specific sequence interactions and C-terminal arginine/serine
(RS)-rich dipeptide domains that regulate protein-protein
interactions and thereby mediate the recruitment of the spli-
ceosome (14). The RS domain plays a role as a nuclear localiza-
tion signal that specifically targets nuclear speckles (15). Phos-
phorylation at multiple serine residues influences efficient
nuclear speckle assembly, pre-mRNA splicing, and mRNA
nuclear export (16). However, the role of the RS-like region
in NSrp70 is still unclear. Therefore, we investigated whether
NSrp70 exerts its function via direct binding to target RNA or
whether it binds indirectly through the RS domains of SRSF1
and SRSF2.
Herewe report thatNSrp70 displayed the opposite activity to
SRSF1 and SRSF2 in the alternative splicing of the CD44 exon
v5 minigene. Furthermore, mutagenesis studies revealed that
the first RS-like region ofNSrp70 is critical for its activity, inter-
acting with the two SR proteins and directly with targetmRNA.
We found that the CC domain is essential for condensational
assembly and that disruption of the CC domain by site-directed
mutagenesis results in indefinite formation of nuclear speckles
and NSrp70 dysfunction.
Experimental Procedures
Reagents and Antibodies—Anti-human NSrp70 (CCDC55)
antibody, glutaraldehyde solution, and His-selected nickel
affinity gel were purchased from Sigma-Aldrich (St. Louis,
MO). Anti-myc and anti--actin antibodies were purchased
from Cell Signaling Technology (Beverly, MA). Total RNA iso-
lation reagent was purchased fromMolecular Research Center,
Inc. (Cincinnati, OH). Reverse transcript PCR premix and con-
ventional PCR premix were purchased from iNtRON Biotech-
nology (Seongnam-si, Gyeonggi-do, Korea). TheMagna RIPTM
kit was purchased from EMD Millipore (Billerica, MA). Texas
Red-conjugated anti-mouse IgG and Lipofectamine 2000 re-
agent were acquired from Life Technologies. Rabbit polyclonal
anti-GFP antibody was developed in rabbit using purified
recombinant full-length GFP protein. Non-muscle actin-de-
rived from human platelets was purchased from Cytoskeleton
Inc. (Denver, CO). Bis(sulfosuccinimidyl) suberate (BS3) was
purchased fromThermoScientific (Waltham,MA).All cell cul-
ture materials used in this work were from Life Technologies.
Cell Culture and Transfection—HEK293T cells (CRL-1573,
ATCC) were maintained in DMEM supplemented with 10%
FBS, penicillin, and streptomycin. Constructs were transfected
by Lipofectamine 2000 (Life Technologies) in HEK293T cells
according to the instructions of the manufacturer instructions.
48 h after transfection, cells were collected for RNAand protein
purification or image analysis.
Plasmids—The mammalian expression vectors pEGFP-C1_
SRSF1 (ASF/SF2) and pETv5_CD44 and the pCR3.1_
MGTra minigenes were gifts from Dr. Brian J. Morris (Univer-
sity of Sydney, NSW, Australia). pEGFP-C1_PML3 was
obtained fromDr. David J. Picketts (University of Pennsylvania,
School of Medicine, Philadelphia, PA). The pEGFP-C1 or
pCS4–3Myc_NSrp70, _SRSF1, and _SRSF2 constructs were
generated using a method reported previously (9).
To produce His-tagged NSrp70, CCD, and RS1M recombi-
nant proteins, the pET-28a vector was used as an expression
vector. This has a T7 promoter and incorporates six His resi-
dues at the N terminus of the expressed protein. The coding
sequences of NSrp70 and mutant NSrp70 were amplified by
PCR, and the products were incorporated into pET-28a.
Purification of Recombinant Proteins—Expression of recom-
binant proteins in Escherichia coli BL21 (DE3) cells was per-
formed as described previously (9). Expression of recombinant
proteins was induced by addition of isopropyl -D-1-thiogalac-
topyranoside (0.3 mM) to culture medium for 16 h at 28 °C, and
then cells were collected. The cell pellets were resuspended in
PBS (0.1 mM CaCl2, 1 mM MgCl2, and 4% sucrose), sonicated,
and centrifuged. After centrifugation, recombinant proteins in
the supernatant were purified by affinity chromatography on a
His-selected nickel affinity gel (Sigma-Aldrich). The gel was
equilibrated with 10 volumes of buffer (50 mM sodium phos-
phate (pH 8.0), and 0.3 M NaCl) and incubated with the super-
natant. The gel waswashedwith five volumes of wash buffer (50
mM sodium phosphate (pH 8.0), 0.3 M NaCl, and 10 mM imid-
azole). The protein was eluted with increasing concentrations
of imidazole up to 250 mM, and the collected fractions were
dialyzed to remove imidazole. The proteins were assessed by
SDS-PAGE and Coomassie blue staining.
In Vivo Splicing Assays—In vivo splicing assays were per-
formed essentially as described previously (17). Briefly, a splic-
ing reporter minigene was cotransfected with an increasing
amount of wild-type or mutant GFP_NSrp70 or Myc_NSrp70
constructs together with GFP- or Myc-tagged SRSF1 and
SRSF2 inHEK293T cells. Empty plasmidswere added to ensure
that the same amount of DNAwas transfected. 48 h after trans-
fection, total RNA was extracted from cells using Total RNA
isolation reagent (Molecular Research Center, Inc.). The cDNA
was transcribed from2g of total RNAusing reverse transcrip-
tion PCR premix (iNtRON Biotechnology). PCR for the CD44
minigene was performed as described previously (9). The PCR
products were analyzed with a 1–1.5% agarose gel, and the
splicing pattern was quantified using ImageJ (National Insti-
tutes of Health).
Immunoprecipitation andWestern Blotting—HEK293T cells
(1  107) transfected with the indicated constructs were lysed
using lysis buffer (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1%
Triton X-100, and one tablet of EDTA-free protease inhibitor
mixture (Roche)) for 30 min on ice. Cell lysates were centri-
fuged at 14,000 g for 30min at 4 °C. Approximately 0.5 mg of
extract was mixed with anti-GFP antibody-conjugated Sephar-
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ose 4B (GE Healthcare Life Sciences). The immunocomplexes
were incubated overnight at 4 °C with frequent mixing, washed
three times each with washing buffer I (20 mM Tris-HCl (pH
7.5), 150mMNaCl, and 1% Triton X-100) and washing buffer II
(20 mM Tris-HCl (pH 7.5) and 150 mM NaCl) and resolved by
10–12%SDS-PAGE. Proteinswere electroblotted on to a PVDF
membrane (PerkinElmer Life Sciences) by means of a Trans-
Blot SD semidry transfer cell (Bio-Rad). The membrane was
blocked in 5% skim milk for 1 h, rinsed, and incubated with
the indicated antibodies in TBS containing 0.1% Tween-20
(TBS-T) and 3% skim milk overnight. Excess primary antibody
was removed by washing the membrane three times in TBS-T.
Themembrane was then incubated with 0.1g/ml peroxidase-
labeled secondary antibody (against rabbit or mouse) for 1 h.
After three washes in TBS-T, bands were visualized by ECL
Western blotting detection (iNtRON Biotechnology).
RNA Immunoprecipitation—RNA immunoprecipitation
(RIP) experiments were performed using a Magna RIP RNA-
binding protein immunoprecipitation kit according to the
instructions of the manufacturer (Millipore) using a modified
version of a method described previously (18). Briefly,
HEK293T cells (1  107) transfected with the indicated con-
structs were lysed on ice in complete RIP lysis buffer (Milli-
pore). NSrp70 antibody or rabbit IgG control antibodywas pre-
coated onto magnetic bead protein A/G for 30 min at room
temperature. Antibody-coated beads were washed twice with
RIPwash buffer (Millipore) using amagnetic separator. Protein
lysates were then incubated with rabbit anti-NSrp70- or rabbit
control IgG-coated beads overnight at 4 °C. The immunopre-
cipitated samples were then centrifuged and washed with ice-
cold RIPwash buffer six times using amagnetic separator. After
the final wash, the RNA-protein complexes were dissociated
from the beads by incubating in proteinase K buffer (Millipore)
for 30 min at 55 °C. The supernatants were collected using a
magnetic separator. RNA extraction from the supernatant was
performed with phenol:chloroform:isoamyl alcohol (125:24:1)
(Sigma-Aldrich) and precipitated using ethanol supplemented
with salt solution I, salt solution II, and precipitation enhancer
overnight. The RNA pellets were then washed and suspended
with RNase-free water. The cDNA was transcribed from total
RNA using reverse transcription PCR Premix (iNtRON
Biotechnology).
PCR was performed with the following primers (the respec-
tive forward and reverse pairs are indicated): endogenousCD44
containing exon v5 (p1 and p2) (19), p1 5-CTGAAGACATC-
TACCCCAGCAAC-3 and p2 5-CAGAAATGGCACCACT-
GCTTAT-3; first v5, 5-AGACAGAATCAGCACCAGTG-3
and 5-TTTTTTTTTTAGGCTGTGGTTCCG-3; and second
v5, 5-CCTTTCAATAACCATGAGTATCAGG-3 and 5-
TTTTTTTTTTTGCTTGTAGCATGTGG-3. The amplifica-
tion protocol consisted of denaturation at 95 °C for 30 s, anneal-
ing at 50–57 °C for 20 s, and extension at 72 °C for 15–17 s. The
30 cycles were preceded by denaturation at 72 °C for 7min. The
three antiparallel minigene CD44 exon v5 RNAs (L, M, and R)
for the RNA competition assay and the CD44 exon v5 mRNA
(first v5 and second v5) were synthesized by Bioneer (Daejeon,
Korea).
Immunofluorescence Staining and Confocal Imaging Anal-
ysis—For visualization of fluorescence, transfected HEK293T
cells were cultured on 18-mm non-coated round coverslips
(Paul Marienfeld GmbH & Co. KG) coated with fibronectin
(Sigma-Aldrich). Cells were fixed with 3.7% formaldehyde for
15min, washed three times with PBS at room temperature, and
permeabilized with 1% BSA and 0.25% Triton X-100 in PBS for
20 min. Cells were then blocked with 1% BSA in PBS for 1 h,
rinsed with PBS, and incubated with primary antibodies in
blocking buffer overnight at 4 °C. Secondary antibodies were
added after washing and incubated for 3 h at room temperature
in the dark before rinsing with PBS. The cells were then washed
and mounted with fluorescent mounting medium (Dako). The
samples were examined with an FV1000 confocal laser-scan-
ning microscope (Olympus) equipped with 40, 60, and
100 objectives.
Protein Cross-linking Assay—For cross-linking of cell lysates,
cells were transfected with the indicated plasmids and lysed
with lysis buffer as described above. Glutaraldehyde (Sigma-
Aldrich) or BS3 (Thermo Scientific) was added to the lysate at
the indicated concentration. After incubating the lysate on ice
for 20 min (glutaraldehyde) or 50 min (BS3), the reactions were
stopped by adding 4 loading buffer, and the samples were
heated at 100 °C for 5min and resolved by SDS-PAGE.Western
blotting analysis was performed as described above. For cross-
linking of recombinant proteins, cell lysates were replaced with
His_NSrp70proteinornon-muscle actin and subsequentlypro-
cessed as described above.
Coiled-Coil Prediction—Coiled-coil prediction was per-
formed using the COILS program. We inserted the amino acid
sequence of wild-type human NSrp70 and mutants to analyze
coiled-coil prediction in the following specific format: window
width, 28; matrix, MTIDK (myosins, tropomysins, intermedi-
ate filaments, desmosomal proteins, and kinesins).
Protein Structural Modeling—Protein sequences of NSrp70
were obtained from the NCBI database (NCBI reference
sequence, NP_115517.1). Structural modeling and three-di-
mensional prediction ofNSrp70were performed using the Iter-
ative Threading Assembly Refinement (I-TASSER) server on
the basis of their confidence score (20). The five models (sup-
plemental Fig. 1) generated were modified and visualized using
the Discovery Studio 4.0 Visualizer program.
Statistical Analysis—Mean values were calculated using data
taken from at least three independent experiments conducted
on different days. Where significance testing was performed,
unpaired Student’s t tests and one-way analysis of variancewere
used. Differences between groups were considered significant
at p 0.05.
Results
NSrp70 Counteracts SRSF1- and SRSF2-induced CD44 Exon
v5 Exclusion—We have reported previously that NSrp70 mod-
ulates alternative splice site selection of some minigenes,
including Tra21, Fas, and CD44. We have also found that
NSrp70 interacts physically with the classical SR proteins
SRSF1 and SRSF2, but its functional relationshipwith these two
splicing factors is uncharacterized. To understand their roles in
relation to the inclusion or exclusion of targetmRNA exons, we
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tested the effects of NSrp70 and two SR proteins on the CD44
exon v5 minigene. Both Myc-tagged SRSF1 (Myc_SRSF1) and
SRSF2 (Myc_SRSF2) increased CD44 exon v5 exclusion in a
transfection concentration-dependent manner (Fig. 1A). On
the contrary, NSrp70 increased CD44 exon v5 inclusion and
blocked SRSF1- or SRSF2-mediated CD44 exon v5 exclusion
(Fig. 1B). To investigate whether alternative site selection of
CD44 exon v5 is dependent on the expression levels of each
splicing factor, HEK293T cells were transfectedwith increasing
or decreasing concentrations of vectors containingNSrp70 and
SRSF1 or SRSF2. RT-PCR showed that NSrp70 and the two SR
proteins have opposite functions and that their actions are
concentration-dependent (Fig. 1, C and D). These results are
interesting because NSrp70 may have an equal competitive
capability against classical SR proteins for alternative splicing
site selection of target pre-mRNA.
NSrp70 Interacts with SRSF1 and SRSF2 through the First
RS-like Region (RS1)—The RS domain in SR proteins has been
demonstrated previously to provide a binding site for other
proteins (21). Previously, we identified that NSrp70 has an RS-
like region that is important for splicing activity and for inter-
action with SRSF1 and SRSF2 (9). To examine which specific
RS-like region influences the activity of NSrp70 against SR pro-
teins, we referred to a previous NSrp70 structure that shows a
predicted coiled-coil domain in the center of the RS-like region
(9). We subdivided the RS-like region into three regions on the
basis of its predicted CC domain (Fig. 6A, right panel) and gen-
erated three deletion mutants, omitting one of each region:
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FIGURE 1.NSrp70 counteracts SRSF1 and SRSF2 to induce alternative splicing of the CD44 exon v5minigene. A, promotion of CD44minigene exon v5
exclusion by SR proteins. HEK293T cells were cotransfected with increasing amounts of Myc_SRSF1 or _SRSF2 (0–2 g) and the CD44 minigene (1 g). A
parental vector (EV, 0–2g) was added to ensure that similar amounts of cDNAwere transfected. Exon inclusion or exclusion was determined by RT-PCR (top
panel). The ratio of exclusion or inclusion of CD44 exon v5 is shown as bar graphs (center panel). Increased expression of Myc_SRSF1 or Myc_SRSF2 was
confirmedbyWesternblottingusing the indicatedantibodies (bottompanel). EV, pCS4–3Myc_empty vector; SR1, SRSF1; SR2, SRSF2;Relative in/ex ratio, relative
inclusion band/exclusion band ratio; IB, immunoblotting;M, molecularmass. B, promotion of CD44minigene exon v5 inclusion byNSrp70. HEK293T cells were
cotransfected with the CD44 minigene (1 g) and Myc_SRSF1 (2 g) or Myc_SRSF2 (2 g) with or without Myc_NSrp70 (2 g). The experiments were
performed as described in A. C and D, NSrp70 counteracts SRSF1 and SRSF2. HEK293T cells were cotransfected with increasing amounts of Myc_NSrp70 (0–2
g) and Myc_SRSF1 (C) or Myc_SRSF2 (0–2 g) (D) and the CD44 minigene (1 g). The experiments were performed as described in A. All data are represen-
tative of three independent experiments. *, p 0.05 versus pCS4–3Myc_empty vector.
NSrp70 Impedes SRSF1 and SRSF2 Splicing Activity
6172 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 291•NUMBER 12•MARCH 18, 2016
 at PO
STECH
 on June 27, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
RS1M, RS2M (CC domain), and RS3M (Fig. 2A). In immuno-
precipitation assays, RS1M showed no interaction with SRSF1
and SRSF2 (Fig. 2B). Furthermore, RS1M showed amarked loss
of speckle localization (Fig. 2C). Interestingly, in the presence of
RS1M or M15 (a mutant with the entire RS-like region dele-
tion), SRSF1 and SRSF2were dispersedwithin the nucleus, sug-
gesting that NSrp70 may be important for the assembly of SR
proteins at nuclear speckles.
NSrp70 Interacts with Target Pre-mRNA through the RS1
Region—We examined whether the RS1 region is also involved
in physical interaction with target mRNA, thereby affecting
splicing function. To this end, we performed an RNA immuno-
precipitation assay using antibodies against GFP_NSrp70. We
found that RS1M showed a complete loss of splicing activity
and that, surprisingly, it was correlated with the loss of RNA
binding for CD44 exon v5 (Fig. 3, A and B). These results sug-
gest that the RS1 region provides a binding site not only for SR
proteins but also for target mRNAs (Fig. 3, A and B). In agree-
ment with this, RS1M could not counteract the alternative
splicing activity of SRSF1 and SRSF2 onCD44 exon v5, whereas
RS2M and RS3M retained complete activity (Fig. 3, C and D).
To extend these findings to a specific functional amino acid
sequence in the RS1 region, we predicted the NSrp70 structure
using the I-TASSER server. This server provided the top four
predictedmodels on the basis of confidence scores. The RS-like
regions (RS1, RS2, and RS3) of NSprp70 were cropped from the
predicted structures and presented (supplemental Fig. 1). We
found that all RS1 regions (amino acids 290–378) are com-
prised of four -helical chains (supplemental Fig. 1). On the
basis of this result, we individually deleted each -helix in the
RS1 region.However, none of deletionmutants showed a loss of
interactionwith SR protein andmRNA comparedwith thewild
type (Fig. 4, B and D). Consistently, these mutants could also
regulate alternative splicing of the CD44 exon v5 inclusion (Fig.
4C). These results demonstrate that the RS1 region is the min-
imum region required for binding to SR proteins and target
mRNA and also for full alternative splicing activity.
The CC Domain of NSrp70 Influences Oligomerization and
Splicing Activity—NSrp70 has an N-terminal CC domain, and
we have demonstrated previously that deletion of the CC
domain (amino acids 1–170) results in loss of NSrp70 alterna-
tive splicing activity. Because the CC domain is known to pro-
mote dimerization (22, 23), we questioned whether NSrp70 is a
dimer, and, if so, whether dimerization is required for its alter-
native splicing activity. To this end, we cotransfectedHEK293T
cells with GFP_NSrp70 and increasing concentrations of
Myc_NSrp70 and performed immunoprecipitation assays with
an antibody against GFP. Western blotting analysis revealed
that Myc_NSrp70 was recovered at GFP_NSrp70-transfected
HEK293T cell samples but not the GFP sample, suggesting that
NSrp70 is a dimer (Fig. 5A). To further confirm the dimeriza-
tion or oligomerization of NSrp70, we also performed a protein
cross-linking assay using glutaraldehyde and BS3. As shown in
Fig. 5B, cell lysates with Myc_NSrp70, but not -actin, were
detected as dimers or trimers, suggesting that NSrp70 exists as
a dimer or multimer under physiological conditions. In addi-
tion, to rule out nonspecific interactions, we performed a cross-
linking assay with purified His-tagged NSrp70 recombinant
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protein and found that His_NSrp70 also showed dimer or
trimer forms after cross-linking (Fig. 5C). To further confirm
that NSrp70 dimerization is mediated by the CC domain, we
predicted the structure of the CC domain-induced multim-
erization using the COILS program (24) (Fig. 6A, right panel)
and then generatedmutants of the CC domain (CC1M, CC2M,
and CCM) using site-directed mutagenesis (Fig. 6A, left panel).
Cross-linking assays revealed that mutation of the CC2 region
(CC2M) significantly reduced dimer or multimer formation
compared with the wild type or CC1M (Fig. 6B).
We next questioned whether oligomerization of NSrp70
affects the alternative splicing of target mRNA. To this end,
HEK293Tcellswere cotransfectedwith each construct (Fig. 6A,
left panel) and with the CD44 exon v5 minigene, and exon
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FIGURE 3. The first RS-like region in NSrp70 is essential for mRNA binding and alternative splicing of CD44 exon v5. A and B, HEK293T cells were
cotransfectedwith GFP_NSrp70wild-type ormutants and the CD44minigene. A, the splicing activity and protein expressionwere determined as described in
Fig. 1A. EV, pEGFP-C1_empty vector; Relative in/ex ratio, relative inclusion band/exclusion band ratio; IB, immunoblotting;M, molecular mass. B, after cell lysis,
the samples were immunoprecipitated with the indicated antibodies (anti-rabbit IgG or anti-GFP), and then the RNAs were purified from the immunoprecipi-
tated samples for RT-PCR. Whole lysates were used as a positive control for CD44 exon v5. Expression of NSrp70, GFP, and -actin was confirmed by Western
blottingwith the indicated antibodies. C andD, the CD44minigene, GFP_NSrp70 constructs, andMyc_SRSF1 orMyc_SRSF2were cotransfected into HEK293T
cells. Splicing activity andprotein expressionweredeterminedasdescribed in Fig. 1A. All data are representative of three independent experiments. *,p0.05
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inclusion was analyzed by RT-PCR. CC2M and CCM both
showed loss of exon inclusion activity compared with the wild
type (Fig. 6C). However, these mutants had a normal binding
affinity for targetmRNA (Fig. 6D), suggesting that NSrp70 olig-
omerization plays a role in splicing activity but not in binding to
target mRNA. Similarly, CCM or CC2M could not block
SRSF1- and SRSF2-mediated CD44 exon v5 exclusion (Fig. 7,A
and B), although thesemutant proteins showed no loss of bind-
ing to SRSF1 and SRSF2 (Fig. 7, C and D).
Finally, we determined whether oligomerization of NSrp70
affects the assembly of nuclear speckles. Interestingly, although
speckles were present, the presence of the CC domain deletion
mutant (1–171) or CCM resulted in no evident speckle
boundary compared with wild-type NSrp70 (Fig. 7E). Taken
together, these results suggest that the CC domain is also
important for the condensational assembly of proteins in
nuclear speckles.
NSrp70 Interacts Directly with Target Pre-mRNA through the
RS1 Region—Our results suggested that the RS1 region of
NSrp70 is important for interaction not only with SR proteins
(SRSF1 and SRSF2) but also with target pre-mRNA, a result
confirmed by RIP. At this point, we raised the question of
whether NSrp70 binds directly to target pre-mRNA or whether
this occurs via an SR protein that could interact with target
pre-mRNA.
Our previous RIP assay (Figs. 3B and 4D) could not exclude
endogenous SR proteins that contained a conserved RRM and
also could not rule out the formation of NSrp70-SR protein
complexes or SRprotein-mRNAcomplexes. To solve this prob-
lem, we utilized recombinant RIP, a RIPmethod described pre-
viously (18). We incubated recombinant His-tagged NSrp70
with total RNA purified from CD44 minigene-transfected
HEK293T cells (Fig. 8A). Subsequent steps were performed as
for the conventional RIP method. Finally, we found that
NSrp70 could interact directly with target pre-mRNA com-
pared with the negative control (Fig. 8A). Interestingly, RS1M
could not immunoprecipitate CD44 exon v5 as well as endoge-
nous CD44 containing variable exon 5, suggesting that RS1 is a
critical region for target RNA binding (Fig. 8B).
As shown in Fig. 8, A and B, NSrp70 binds the CD44 mini-
gene not only with exon v5 (2 5 3) but also without v5 (2
3). These results led us to address whether the RS1 region binds
directly to exon v5 of CD44 mRNA. We therefore partially
mapped the specific site of CD44 exon v5 interaction with the
RS1 region ofNSrp70. AnRNA competition assay revealed that
the mid (M) region of CD44 exon v5 is most important for
binding toNSrp70 but that the other regions also affect binding
affinity (Fig. 8C). To further confirm the specific binding
sequences in CD44 exon v5, we synthesized two separate parts
(first v5 and second v5) of CD44 exon v5 RNAs tagged with 10
adenine nucleotides (Fig. 8D, top panel).Wild-typeNSrp70, but
not RS1M, could immunoprecipitate the second region of
CD44 exon v5 (Fig. 8D). Combined with the results of the RNA
competition assay (Fig. 8C), these results demonstrate that the
RS1 region of NSrp70 binds directly to the mid-to-rear region
of CD44 exon v5.
Discussion
Expression of the cell surface molecule CD44 is an excellent
example of alternative splicing, and, therefore, CD44 exon v5
has been investigated extensively (25, 26). In this work, we
found that the SR proteins SRSF1 and SRSF2 induce exclusion
of CD44 exon v5 in a concentration-dependent manner. Inter-
estingly, however, we observed thatNSrp70 blocks the function
A
Coiled-coil RS-like NLS
RS1-4M
(Δ355-378) GFP
379354
RS1-3M
(Δ342-354) GFP
355341
RS1-2M
(Δ305-341) GFP
341
RS1-1M
(Δ290-304) GFP
289
304
305
B
SRSF1
SRSF1
GFP
E
V
N
sr
p7
0
R
S
1M
R
S
1-
1M
R
S
1-
2M
R
S
1-
3M
R
S
1-
4M
+ Myc_SRSF1
IP: α-GFP  IB: α-Myc 
IB: α-Myc
IB: α-GFP
SRSF2
SRSF2
GFP
E
V
N
S
rp
70
R
S
1M
R
S
1-
1M
R
S
1-
2M
R
S
1-
3M
R
S
1-
4M
+ Myc_SRSF2
IP: α-GFP  IB: α-Myc 
IB: α-Myc   
IB: α-GFP
GFP: GFP:
DC
E
V
N
sr
p7
0
R
S
1M
R
S
1-
1M
R
S
1-
2M
R
S
1-
3M
R
S
1-
4M
IB: α-GFP
IB: α- actin
actin
+ CD44 minigene 
GFP
E
V
N
S
rp
70
N
S
rp
70
R
S
1M
R
S
1-
1M
R
S
1-
2M
R
S
1-
3M
R
S
1-
4M
Whole lysate
GFP:
IB: α-GFP
GFP
+ CD44 minigene 
IB: α-
α-GFP  α-Rbbit 
IgG
GFP:
95
92
95
94
M
34
34
M
27
37
37
M
27
GAPDH
(250 bp)
42
27
42
MM
27
NSrp70
(267 bp)
32
52 3
32
52 3
32
52 3
70
100
70
100
100 100
Antibodies
for RIP
0
0.5
1
1.5
2
2.5
3R
el
at
iv
e 
in
/e
x 
ra
tio
* * *
* *
NSrp70 &
mutants
NSrp70 &
mutants
NSrp70 &
mutants
NSrp70 &
mutants
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molecular mass; NLS, nuclear localization signal. B, HEK293T cells were
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of two of these SR proteins and induces inclusion of CD44 exon
v5. Physical interactionwith SRproteins andwith targetmRNA
was critical for the NSrp70-induced inclusion of CD44 exon v5.
TheRS1 region provided a binding site for both SRproteins and
CD44mRNA. Therefore, RS1 deletion significantly diminished
speckle localization of NSrp70. Moreover, RS1 deletion
resulted in dispersed localization of SRSF1 and SRSF2 in the
nucleus, suggesting that NSrp70 may act as a molecular scaf-
fold and recruit other proteins for nuclear speckle organiza-
tion. The N-terminal coiled-coil domain is important for the
oligomerization of NSrp70 and also influences the activity of
NSrp70.
A previous model of SRSF1 activity in CD44 exon v5 splicing
proposed that SRSF1 has a RNA-binding specificity for the
purine-rich splicing enhancer (27) and that the CD44 exon v5
region consists of a purine-rich exon splicing enhancer site (28).
This model suggested that SRSF1 increases CD44 exon v5
inclusion through interference with the repressive activity of
heterogeneous nuclear ribonucleoprotein, which is known to
counteract the activity of SRSF1 (29, 30). However, we unex-
pectedly found that both SRSF1 and SRSF2 increase CD44 exon
v5 exclusion in a concentration-dependent manner, suggesting
that SRSF1 is not always specific for exon inclusion butmay also
be involved in exon exclusion. In agreement with this, a recent
genome-wide analysis has revealed that SR proteins (SRSF1–4)
cause similar numbers of exon inclusion and exon inclusion
events (31–33). This finding suggests that the combinational
contents of the splicing machinery complex are more impor-
tant for alternative splicing than the specific mRNA interaction
tendency of a single SR protein. Although a more detailed
understanding of the mechanisms of NSrp70 function are
needed, these results suggest that, after site selection, there are
further, more complicated mechanisms to determine exon
inclusion or exclusion of certainmRNAs. Another possibility is
that the composition of the RNA splicing assembly may be
another determinant for site selection.
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In a previous report, we observed that NSrp70 has an RS-
like region (amino acids 290–471) that is important for the
alternative site selection of several minigenes. On the basis
of these results, we hypothesized that binding of NSrp70 to
SRSF1 through this domain is critical to suppress the nega-
tive function of SRSF1 on CD44 exon v5 inclusion. Indeed,
the RS domain has been proposed to mediate protein-pro-
tein interactions for spliceosomal recruitment and nuclear
speckle assembly (34, 35). Therefore, the interaction between
NSrp70 and SRSF1 and SRSF2 through the RS-like region is not
surprising, although this domain was not a typical RS domain
containing 40% of a consecutive RS sequence (9, 36). In the
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results presented here, however, it is interesting to note that
binding to SRSF1 and SRSF2 only involves the first RS1 region.
However, further subdivision of RS1 regions had no effect, sug-
gesting that RS1 is the minimum region required for binding to
SRSF1 and SRSF2 and to target mRNA.
An important question raised at this point was how the RS1-
like region binds to both SR proteins and mRNA simultane-
ously. Several reports have demonstrated that SR proteins bind
to protein andmRNA through two separate domains: the RRM
and RS domains. Of interest is that NSrp70 binds both proteins
and mRNA through only one RS1-like region. Because the
sequence of the RS1-like region in NSrp70 is different from the
typical RRM and RS domain and because it only has a few SR
dipeptides with no concomitant features of an RRM (9), we
suggest here a unique function of the RS1-like region: to recruit
both interacting proteins and mRNA simultaneously. To
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FIGURE 8.NSrp70 binds directly to targetmRNA. A, recombinant His_NSrp70 (100–500 ng) proteins weremixed with total RNA (50g) purified from CD44
minigene-transfected HEK293T cells. RNA-protein complexes were immunoprecipitated with the indicated antibodies (Abs, anti-rabbit IgG or anti-NSrp70).
RNAs were purified from the immunoprecipitation sample, and then RT-PCR was performed for CD44. As a loading control, the existence of CD44mRNAwas
confirmed from each sample by RT-PCR. Concentrations of recombinant His_NSrp70 were confirmed byWestern blotting with -NSrp70 antibody.M, molec-
ular mass; IB, immunoblotting. B, recombinant His_NSrp70 (100 ng) and His_RS1M (500 ng) were mixed with total RNA (50g) purified from CD44minigene-
transfected HEK293T cells. The RIP assay was performed as described above (A). CD44s, CD44 standard isoform; endogenous CD44 (v5), endogenous CD44
containing exon v5; p1, CD44v5p1primer; p2, CD44v5p2primer.C, for the RNA competition assay, total RNA (20g) purified fromCD44minigene-transfected
HEK293T cellswas incubatedwith antiparallelminigeneCD44exonv5RNA (L,M,R). After incubation for 10min, the RNAmixturesweremixedwithHis_NSrp70
(100 ng). The RIP assay was performed as described above (A). nt, nucleotide number; L, left sequence;M, middle sequence; R, right sequence. D, His_NSrp70
(100 ng) and His_RS1M (500 ng) were mixed with synthesized RNAs as shown (first and second region of CD44 exon v5). The RIP assay was performed as
described above (A). All data are representative of three independent experiments. dA, adenine.
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understand this, we modeled the NSrp70 structure using the
I-TASSER server and found that the RS1-like region consisted
of only an  helix (supplemental Fig. 1). In general, the compo-
nents ofmost RRM- and RNA-binding domains have an helix
and  sheets together (37). Interestingly, there are two proteins
that contain only an -helix in the RNA binding domain:
Pumilio and Vts1. These proteins contain a pumilio domain
and a sterile alpha motif (SAM) domain, respectively (38, 39).
Especially the predicted structure of the RS1-like region in
NSrp70 is similar to the pumilio domain, and the sequence
identity between the two domainswas lower than 20% (data not
shown). The property of the pumilio domain to bind the inter-
acting proteins in addition to mRNA also suggests a similar
function with NSrp70. Another study is now underway to iden-
tify whether the two proteins, NSrp70 and pumilio, have any
functional similarity.
Proteins containing the CC domain are known to induce
homophilic oligomerization throughdimeric or trimetric inter-
actions (40, 41). Consistent with this, we found that NSrp70
could self-interact to form multimers through the CC domain
and that multimerization influenced its alternative splicing
activity but had no effect on binding to SR proteins or to target
mRNA. These results suggest that, although the CC domain
does not directly affect the activity of NSrp70, it may affect
activity indirectly by modulating nuclear speckle organization.
Recently, several reports have suggested that RNA-binding
proteins are involved in functional aggregation, forming paras-
peckles in the nucleus and RNA-protein granules, known as
stress granules, in the cytoplasm (10). For example, proteins of
the DBHS family, including SFPQ (PSF), NONO (p54nrb), and
PSPC1, are major components of paraspeckles and can modu-
late paraspeckle formation in the nucleus (11). Proteins of the
DBHS family have two RRMs at the N terminus, a conserved
core domain known as NONA/paraspeckle, and a CC domain
at the C terminus. Crystal structures of DBHS family members
have revealed that these proteins polymerize into infinite linear
self-dimer structures through the CC domain, which is impor-
tant for DBHS proteins targeting paraspeckles (12, 13). DBHS
proteins bind to target DNA or NEAT1 as scaffolding long-
noncoding RNA for paraspeckle formation, and this unique
ability to polymerize in a linear pattern helps these proteins to
localize to the condensational assembly binding site, providing
enriched recruitment of other functional factors. This could
rapidly promote a specific response, such as DNA damage
repair or a transcriptional event. Indeed, these self-associated
oligomers are connected with recent themes of higher-order
assemblies in signaling complexes leading to signal amplifica-
tion, reduction of biological noise, and temporal and spatial
control of signal transduction (42).
Althoughwe discovered that NSrp70 counteracts SRSF1 and
SRSF2 in terms of CD44 exon v5 alternative splicing, we do not
yet know whether NSrp70 also effectively blocks SR protein
function in vivo. Interestingly, a previous report has demon-
strated that CD3  chain mRNA in T cells exists as two iso-
forms: a full sequence form and a specific 3UTR-deleted form
that influences mRNA stability, leading to mRNA degradation
(43). Interestingly, we have evidence that ectopic expression of
NSrp70 reduces the expression of the CD3  chain in Jurkat T
cells.3 Further research is underway, but we tentatively suggest
that NSrp70 may act as a negative regulator of T cell activation
through control of mRNA stability against SRSF1 or SRSF2.
We also investigated potential binding proteins of NSrp70
using LC-mass methods and found that the candidate proteins
show a broad spectrum related to gene regulation, including
DNA helicases, small nuclear ribonucleoproteins, heterogene-
ous nuclear ribonucleoproteins, SR proteins, exon junction
complex proteins, and ribosomal proteins.3 These results indi-
cate that NSrp70 may be involved in many physiological pro-
cesses. Interestingly, we found recently that the level of NSrp70
is reduced dramatically during T cell activation in response to
anti-CD3/28 antibodies, suggesting that NSrp70 is an impor-
tant regulator of T cell activation or differentiation. Further
studies are now in progress to elucidate the global gene expres-
sion profiles that are affected by NSrp70 in T cells.
In conclusion, we identified that NSrp70 has two major
domains. The first is the N-terminal CC domain, which is
important for self-interaction, allowing NSrp70 to form multi-
mers that influence nuclear speckle organization and NSrp70
activity. The second is the RS1 region, which provides a binding
site for the SR proteins SRSF1 and SRSF2 and also for target
mRNA. The opposing splicing activity of NSrp70 compared
with SRSF1 and SRSF2 suggests that it acts as a molecular bal-
ancer for the expression of certain genes whose expression is
controlled by SRSF1 and SRSF2. Further study, in addition to
these results, of this novel splicing factor may provide us with
new insights into RNA biogenesis and protein isoform
regulation.
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